Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

W003 - Hands-on: Practical Anatomy for Dermal Fillers

Monday, February 19; 9:00 AM - 12:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify structural and functional facial anatomy relevant to filler injections.
  • Utilize proper techniques for soft tissue augmentation pan-facially.
  • Implement peri-procedural assessment and strategies for avoidance and management of complications.


This hands-on training session for dermal fillers will begin with a video review of anatomy presented by Dr. Braz. Participants will then break into groups of beginner/intermediate or intermediate/advanced injectors. Faculty will circulate through each of stations focused on a specific anatomical region of the face. Each demonstration table will be equipped with high fidelity cutaneous surgical training models for practice injections using both needles and cannulas. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.


  • Braz, Andre, MD: Allergan, Inc – A(H), SP(H); Merz Pharmaceuticals, LLC – SP(Fees);
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – I(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – SH(ST); Valeant Pharmaceuticals North America LLC – C(H);
  • Fabi, Sabrina G., MD: Alastin Skincare, Inc – A(H); Allergan, Inc – I(Grants/Research Funding), Speaker/Faculty Education(H); AmperSand Biopharmaceutical, LLC – I(Grants/Research Funding); Bayer – I(Grants/Research Funding); Colorescience – I(Grants/Research Funding), Speaker/Faculty Education(H); Endo International plc – I(Grants/Research Funding); Galderma Laboratories, LP – SP(H); Merz Aesthetics – I(Grants/Research Funding), Speaker/Faculty Education(H); Revance Therapeutics, Inc. – A(H), I(Grants/Research Funding);
  • Green, Jeremy, MD: Aclaris Therapeutics Inc. – A(H); Allergan, Inc – A(H), I(Grants/Research Funding), SP(H); Bonti – A(H); Brickell Biotech, Inc. – I(Grants/Research Funding); Candesant Biomedical, Inc. – I(Grants/Research Funding), SH(ST); Clarisonic – A(H); Cutera, Inc. – SP(H); Cynosure, Inc. – SP(EQ); Endo International plc – A(H); Evolus, Inc. – A(H); Galderma Laboratories, L.P. – I(Grants/Research Funding), SP(H); Galderma USA – A(H); Lutronic – I(Grants/Research Funding); Merz Aesthetics – A(H), I(Grants/Research Funding), SP(H); Revance Therapeutics, Inc. – A(H), I(Grants/Research Funding); Sienna Labs, Inc. – A(H), I(Grants/Research Funding);
  • Matarasso, Seth L., MD: no financial relationships exist with commercial interests.
  • Palm, Melanie, MD: Allergan, Inc – A(H); AmperSand Biopharmaceutical, LLC – I(Fees); BTL Industries – Speaker/Faculty Education(H); Galderma Laboratories, L.P. – C(H); Kythera – Speaker/Faculty Education(H); Lumenis – SP(H); Lutronics, Inc. – C(OB); Merz Aesthetics – Speaker/Faculty Education(H); Valeant Pharmaceuticals International – C(H);
  • Weinkle, Susan H., MD: Allergan, Inc – C(H), I(H); Allergan, Inc. – A(H), SP(H); Alphaeon – I(H); Derm Advance – I(NC), SH(NC); Ethicon, Inc. – A(H), C(H), SP(H); Galderma Laboratories, L.P. – C(H), SP(H); Merz Aesthetics – A(H), C(H), SP(H); Procter & Gamble Company – C(H); Sinclair Pharma – C(H), I(H); TEOXANE Laboratories – I(H);
Event Details
  • Date
    Monday, February 19
  • Time
    9:00 AM - 12:00 PM
  • Location
    Room 9
  • CME Credits
  • Type
  • Sue Ellen Cox, MD, FAAD
  • Andre Braz, MD
  • Jeremy Green, MD, FAAD
  • Melanie Palm, MD, FAAD
  • Sabrina G. Fabi, MD, FAAD
  • Seth L. Matarasso, MD, FAAD
  • Susan H. Weinkle, MD, FAAD